Japanese Encephalitis Virus Discovery: A Historical Overview

Discovery of Japanese Encephalitis Virus (JEV)

In 1935, Japanese virologist Sunao Ishiwara successfully isolated the Japanese encephalitis virus from the brain tissue of a fatal human case in Nagasaki Prefecture. This breakthrough followed a major 1924 epidemic in Japan (≈6,000 cases, 3,800 deaths) that spurred intensive research.

Historical Context

  • 1871: First clinical description of "summer encephalitis" in Japan.
  • 1924: Large epidemic prompts national investigation.
  • 1933: Hayashi et al. transmit disease to monkeys via infected mosquito (Culex tritaeniorhynchus) and brain suspension.
  • 1935: Ishiwara isolates virus in mouse brain; confirms filterability and pathogenicity.
  • 1938: Virus named "Japanese B encephalitis virus" to distinguish from von Economo's encephalitis lethargica.

Significance

  • Enabled vaccine development (first inactivated mouse-brain vaccine 1940s; modern Vero-cell vaccines).
  • Allowed vector ecology studies: pig amplification hosts, Culex vectors, rice paddy ecology.
  • Facilitated serologic surveillance across Asia.

JEV remains the leading cause of viral encephalitis in Asia, with ~68,000 clinical cases annually. Ishiwara's isolation was pivotal for all subsequent control efforts.

Viral Infections - Related Articles